• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

偏倚风险评估:(8) 系统评价中的偏倚风险 (ROBIS)

[Risk of bias assessment: (8) Risk of Bias in Systematic Review (ROBIS)].

作者信息

Hu J, Sun F, Zhan S Y

机构信息

Center of Evidence-based Medicine, Beijing Traditional Chinese Medicine Hospital, Capital Medical University, Beijing Institute of Traditional Chinese Medicine, Beijing 100010, China.

Department of Epidemiology and Biostatistics, School of Public Health, Center of Evidence-based Medicine and Clinical Research, Peking University, Beijing 100191, China.

出版信息

Zhonghua Liu Xing Bing Xue Za Zhi. 2018 Aug 10;39(8):1125-1129. doi: 10.3760/cma.j.issn.0254-6450.2018.08.022.

DOI:10.3760/cma.j.issn.0254-6450.2018.08.022
PMID:30180441
Abstract

This paper introduces the Risk of Bias in Systematic Review (ROBIS), including: 1) the development of ROBIS, 2) three phases of ROBIS tool judging the overall risk of bias that related to systematic reviews, and 3) illustration on the application of ROBIS in a published systematic review. ROBIS is the first rigorously developed tool which is specifically designed to assess the risk of bias in systematic reviews. ROBIS will help improve the process of risk assessment on bias which appeared in overviews and guidelines.

摘要

本文介绍了系统评价中的偏倚风险(ROBIS),包括:1)ROBIS的开发;2)ROBIS工具判断与系统评价相关的总体偏倚风险的三个阶段;3)ROBIS在一篇已发表的系统评价中的应用示例。ROBIS是首个经过严格开发、专门用于评估系统评价中偏倚风险的工具。ROBIS将有助于改进对综述和指南中出现的偏倚进行风险评估的过程。

相似文献

1
[Risk of bias assessment: (8) Risk of Bias in Systematic Review (ROBIS)].偏倚风险评估:(8) 系统评价中的偏倚风险 (ROBIS)
Zhonghua Liu Xing Bing Xue Za Zhi. 2018 Aug 10;39(8):1125-1129. doi: 10.3760/cma.j.issn.0254-6450.2018.08.022.
2
ROBIS: A new tool to assess risk of bias in systematic reviews was developed.ROBIS:一种用于评估系统评价中偏倚风险的新工具被开发出来。
J Clin Epidemiol. 2016 Jan;69:225-34. doi: 10.1016/j.jclinepi.2015.06.005. Epub 2015 Jun 16.
3
[ROBIS: a new tool to assess risk of bias in systematic reviews was developed.].[ROBIS:一种用于评估系统评价中偏倚风险的新工具被开发出来。]
Recenti Prog Med. 2018 Sep;109(9):421-431. doi: 10.1701/2990.29928.
4
A comparison of two assessment tools used in overviews of systematic reviews: ROBIS versus AMSTAR-2.两种用于系统评价概述评估工具的比较:ROBIS 与 AMSTAR-2。
Syst Rev. 2021 Oct 25;10(1):273. doi: 10.1186/s13643-021-01819-x.
5
Minor differences were found between AMSTAR 2 and ROBIS in the assessment of systematic reviews including both randomized and nonrandomized studies.在评估包括随机和非随机研究的系统综述时,AMSTAR 2 与 ROBIS 之间存在细微差异。
J Clin Epidemiol. 2019 Apr;108:26-33. doi: 10.1016/j.jclinepi.2018.12.004. Epub 2018 Dec 10.
6
Quality assessment versus risk of bias in systematic reviews: AMSTAR and ROBIS had similar reliability but differed in their construct and applicability.系统评价中的质量评估与偏倚风险:AMSTAR 和 ROBIS 具有相似的可靠性,但在结构和适用性上有所不同。
J Clin Epidemiol. 2018 Jul;99:24-32. doi: 10.1016/j.jclinepi.2018.02.024. Epub 2018 Mar 8.
7
Quality and risk of bias appraisals of systematic reviews are inconsistent across reviewers and centers.系统评价的质量和偏倚评估在评审员和中心之间存在不一致性。
J Clin Epidemiol. 2020 Sep;125:9-15. doi: 10.1016/j.jclinepi.2020.04.026. Epub 2020 May 19.
8
A Critical Overview of Systematic Reviews of Chemotherapy for Advanced and Locally Advanced Pancreatic Cancer using both AMSTAR2 and ROBIS as Quality Assessment Tools.采用 AMSTAR2 和 ROBIS 作为质量评估工具对晚期和局部晚期胰腺癌化疗的系统评价进行批判性概述。
Rev Recent Clin Trials. 2021;16(2):180-192. doi: 10.2174/1574887115666200902111510.
9
A psychometric study found AMSTAR 2 to be a valid and moderately reliable appraisal tool.一项心理计量研究发现 AMSTAR 2 是一个有效且具有中等可靠性的评价工具。
J Clin Epidemiol. 2019 Oct;114:133-140. doi: 10.1016/j.jclinepi.2019.05.028. Epub 2019 May 29.
10
Similarities, reliability and gaps in assessing the quality of conduct of systematic reviews using AMSTAR-2 and ROBIS: systematic survey of nutrition reviews.使用 AMSTAR-2 和 ROBIS 评估系统评价的实施质量的相似性、可靠性和差距:营养评价的系统调查。
BMC Med Res Methodol. 2021 Nov 27;21(1):261. doi: 10.1186/s12874-021-01457-w.

引用本文的文献

1
The safety and feasibility of transoral thyroidectomy vestibular approach in the treatment of thyroid disorders: An overview of systematic reviews.经口前庭入路甲状腺切除术治疗甲状腺疾病的安全性和可行性:系统评价综述
PLoS One. 2025 Jul 2;20(7):e0326318. doi: 10.1371/journal.pone.0326318. eCollection 2025.
2
The impact of bias of underlying literature in guidelines on its recommendations: assessment of the German fluoride guideline.指南中基础文献偏倚对其推荐的影响:德国氟化物指南的评估。
Eur Arch Paediatr Dent. 2024 Feb;25(1):65-73. doi: 10.1007/s40368-023-00854-7. Epub 2023 Nov 26.